使用开源数据协调工具在重症监护中获得真实世界证据的途径。

Smith F Heavner, Wesley Anderson, Rahul Kashyap, Pamela Dasher, Ewy A Mathé, Laura Merson, Philippe J Guerin, Jeff Weaver, Matthew Robinson, Marco Schito, Vishakha K Kumar, Paul Nagy
{"title":"使用开源数据协调工具在重症监护中获得真实世界证据的途径。","authors":"Smith F Heavner,&nbsp;Wesley Anderson,&nbsp;Rahul Kashyap,&nbsp;Pamela Dasher,&nbsp;Ewy A Mathé,&nbsp;Laura Merson,&nbsp;Philippe J Guerin,&nbsp;Jeff Weaver,&nbsp;Matthew Robinson,&nbsp;Marco Schito,&nbsp;Vishakha K Kumar,&nbsp;Paul Nagy","doi":"10.1097/CCE.0000000000000893","DOIUrl":null,"url":null,"abstract":"<p><p>COVID-19 highlighted the need for use of real-world data (RWD) in critical care as a near real-time resource for clinical, research, and policy efforts. Analysis of RWD is gaining momentum and can generate important evidence for policy makers and regulators. Extracting high quality RWD from electronic health records (EHRs) requires sophisticated infrastructure and dedicated resources. We sought to customize freely available public tools, supporting all phases of data harmonization, from data quality assessments to de-identification procedures, and generation of robust, data science ready RWD from EHRs. These data are made available to clinicians and researchers through CURE ID, a free platform which facilitates access to case reports of challenging clinical cases and repurposed treatments hosted by the National Center for Advancing Translational Sciences/National Institutes of Health in partnership with the Food and Drug Administration. This commentary describes the partnership, rationale, process, use case, impact in critical care, and future directions for this collaborative effort.</p>","PeriodicalId":10759,"journal":{"name":"Critical Care Explorations","volume":"5 4","pages":"e0893"},"PeriodicalIF":0.0000,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/5c/2c/cc9-5-e0893.PMC10072311.pdf","citationCount":"0","resultStr":"{\"title\":\"A Path to Real-World Evidence in Critical Care Using Open-Source Data Harmonization Tools.\",\"authors\":\"Smith F Heavner,&nbsp;Wesley Anderson,&nbsp;Rahul Kashyap,&nbsp;Pamela Dasher,&nbsp;Ewy A Mathé,&nbsp;Laura Merson,&nbsp;Philippe J Guerin,&nbsp;Jeff Weaver,&nbsp;Matthew Robinson,&nbsp;Marco Schito,&nbsp;Vishakha K Kumar,&nbsp;Paul Nagy\",\"doi\":\"10.1097/CCE.0000000000000893\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>COVID-19 highlighted the need for use of real-world data (RWD) in critical care as a near real-time resource for clinical, research, and policy efforts. Analysis of RWD is gaining momentum and can generate important evidence for policy makers and regulators. Extracting high quality RWD from electronic health records (EHRs) requires sophisticated infrastructure and dedicated resources. We sought to customize freely available public tools, supporting all phases of data harmonization, from data quality assessments to de-identification procedures, and generation of robust, data science ready RWD from EHRs. These data are made available to clinicians and researchers through CURE ID, a free platform which facilitates access to case reports of challenging clinical cases and repurposed treatments hosted by the National Center for Advancing Translational Sciences/National Institutes of Health in partnership with the Food and Drug Administration. This commentary describes the partnership, rationale, process, use case, impact in critical care, and future directions for this collaborative effort.</p>\",\"PeriodicalId\":10759,\"journal\":{\"name\":\"Critical Care Explorations\",\"volume\":\"5 4\",\"pages\":\"e0893\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/5c/2c/cc9-5-e0893.PMC10072311.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Critical Care Explorations\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1097/CCE.0000000000000893\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Critical Care Explorations","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/CCE.0000000000000893","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

COVID-19突出了在重症监护中使用真实世界数据(RWD)作为临床、研究和政策工作的近实时资源的必要性。对RWD的分析正在获得动力,可以为政策制定者和监管机构提供重要证据。从电子健康记录(EHRs)中提取高质量的RWD需要复杂的基础设施和专用资源。我们试图定制免费可用的公共工具,支持数据协调的所有阶段,从数据质量评估到去识别程序,以及从电子病历生成稳健的、数据科学就绪的RWD。临床医生和研究人员可以通过CURE ID获得这些数据。CURE ID是一个免费平台,便于获取具有挑战性的临床病例报告和重新利用的治疗方法,该平台由美国国家促进转化科学中心/美国国立卫生研究院与美国食品和药物管理局合作主办。这篇评论描述了合作伙伴关系、基本原理、过程、用例、对重症监护的影响,以及这一合作努力的未来方向。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

摘要图片

摘要图片

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
A Path to Real-World Evidence in Critical Care Using Open-Source Data Harmonization Tools.

COVID-19 highlighted the need for use of real-world data (RWD) in critical care as a near real-time resource for clinical, research, and policy efforts. Analysis of RWD is gaining momentum and can generate important evidence for policy makers and regulators. Extracting high quality RWD from electronic health records (EHRs) requires sophisticated infrastructure and dedicated resources. We sought to customize freely available public tools, supporting all phases of data harmonization, from data quality assessments to de-identification procedures, and generation of robust, data science ready RWD from EHRs. These data are made available to clinicians and researchers through CURE ID, a free platform which facilitates access to case reports of challenging clinical cases and repurposed treatments hosted by the National Center for Advancing Translational Sciences/National Institutes of Health in partnership with the Food and Drug Administration. This commentary describes the partnership, rationale, process, use case, impact in critical care, and future directions for this collaborative effort.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
A New Dosing Frontier: Retrospective Assessment of Effluent Flow Rates and Residual Renal Function Among Critically Ill Patients Receiving Continuous Renal Replacement Therapy Hemodynamic Determinants of Cardiac Surgery-Associated Acute Kidney Injury Racial Differences in Accuracy of Predictive Models for High-Flow Nasal Cannula Failure in COVID-19 Knowledge and Practice Gaps in Pediatric Neurocritical Care Nursing: Lessons Learned From a Specialized Educational Boot Camp Unifying Fluid Responsiveness and Tolerance With Physiology: A Dynamic Interpretation of the Diamond–Forrester Classification
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1